CytoDyn Announces Investor Call to Provide Update on Clinical Development Strategy
Click here to view our proxy materials for the meeting to be held on August 20, 2014:
Investor Update Conference Call
©2014 CytoDyn Inc. All Rights Reserved.
Website by Equisolve
The next class of antiviral agents for the treatment of HIV